Studies including clinical samples from the UK [9,10], The Netherlands [11], Finland [12], and Canada [13] have confirmed that, like BRCA2 [14,15], PALB2 is both a breast cancer susceptibility gene and a Fanconi anemia gene. This evidence concerns the gene BRCA2 and breast carcinoma.